Delivery Order SPE2DB20D2104-SPE2DB25FMFSQ
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.26 firm fixed-price delivery order contract is for the supply of 100-count lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,355.83 firm fixed-price delivery order is for the supply of 4,567,074,436 units of the medication lisdexamfetamine 40 mg capsule. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $5,909.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,939,598 units of the drug lisdexamfetamine 10 mg capsules. The contract has an ultimate completion date of January 16, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,312.39 firm fixed-price delivery order is for the provision of 100-count packages of the pharmaceutical drug lisdexamfetamine 50 mg capsules. The award has an ultimate completion date of November 14, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,774.62, is for the delivery of lisdexamfetamine 10 mg capsules in 100-count packages. The contract has an ultimate completion date of February 11, 2025 and is a firm-fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,051.86 firm fixed-price contract is for the supply of 4,567,172,718 units of the prescription drug lisdexamfetamine 10 mg capsules. The award has a period of performance through February 6, 2025 and is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of lisdexamfetamine 30 mg capsules. The $1,345.44 firm fixed price contract has a completion date of February 10, 2025. It was awarded on February 7, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $2,375.59 for the supply of 100 capsules of 30 mg lisdexamfetamine. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 17, 2025, with a completion date of January 21, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,148,024 units of the pharmaceutical drug Lisdexamfetamine 30 mg capsules. The contract has a ceiling value of $1,770.04 and a period of performance through February 5, 2025. The contract is structured as a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and does not have any listed major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,031.80, is a delivery order for the supply of 4,567,202 units of 30 mg Lisdexamfetamine capsules. The contract has a completion date of February 10, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor under this award and has no reported major...